Atessia

Pre-clinical

Paris, FranceFounded 2016atessia.fr

Atessia is a specialized life science advisory firm offering comprehensive regulatory and pharmaceutical affairs consulting services. It differentiates itself through a tailored, agile approach and a 360° vision of regulatory activities, supported by a certified ISO 9001 quality management system. The company serves a diverse client base across multiple locations in France and Luxembourg, focusing on medicines, medical devices, and health vigilance. Its ambition is to create bespoke solutions for clients' most complex regulatory and operational challenges.

Founded

2016

Employees

Focus

CardiovascularMedical Devices

AI Company Overview

Technology Platform

Atessia's core platform is its integrated service delivery model and proprietary 'ATESSIA INTELLIGENCE ACCESS' knowledge system, supported by an ISO 9001-certified quality management system designed for regulatory and pharmaceutical affairs consulting.

Opportunities

Growth opportunities include capitalizing on the increasing complexity of EU medical device regulations (MDR), expanding service offerings in health vigilance and advanced therapy medicinal products (ATMPs), and potentially extending its geographic footprint beyond France and Luxembourg.

The 'Atessia Intelligence' subscription service represents a scalable, recurring revenue opportunity.

Risk Factors

Key risks include dependence on a limited geographic market (France/Luxembourg), high competition for specialized talent, vulnerability to fluctuations in client R&D spending, and the challenge of maintaining a tailored service model while scaling the business.

Its success is intrinsically linked to the reputation and expertise of its individual consultants.

Competitive Landscape

Atessia competes with other regulatory affairs consultancies, from boutique firms to large CROs like Parexel and IQVIA. Its main differentiation is its certified ISO 9001 quality management system for consulting, its promise of a tailored and agile approach, and its integrated '360° vision' of regulatory activities. It positions itself as a strategic partner rather than a mere service provider.